Description
CPRR FOR IFOBT TESTING
Base award description: COST PER TST
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-10-01+$644,717= $644,717
- Mod P000012012-02-16-$100,800= $543,917
- Mod P000032012-06-11-$100,800= $443,117
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-10-01 | +$644,717 | $644,717 | COST PER TST |
| Mod P00001· FUNDING ONLY ACTION | 2012-02-16 | −$100,800 | $543,917 | CPRR FOR IFOBT TESTING |
| Mod P00003· FUNDING ONLY ACTION | 2012-06-11 | −$100,800 | $443,117 | CPRR FOR IFOBT TESTING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI STNDUK44ENE8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0941 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $25,596 | FY2026 |
| 36C24726N0361 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q403 · MEDICAL- EVALUATION/SCREENING | $90,000 | FY2026 |
| 36C25726N0497 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $30,770 | FY2026 |
| 36C24526N0729 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $90,000 | FY2026 |
| 36C24526A0052 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $0 | FY2026 |
| 36C25726N0398 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $68,049 | FY2026 |
Other recipients under 6630 from 586-JACKSON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25615F1053 | ROCHE DIAGNOSTICS CORPORATION | 586-JACKSON | $7,857 | FY2015 |
| VA25613J2493 | ORTHO-CLINICAL DIAGNOSTICS, INC | 586-JACKSON | $62,500 | FY2013 |
| VA25613J2495 | DIAGNOSTICA STAGO INC | 586-JACKSON | $60,934 | FY2013 |
| VA25613J2496 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 586-JACKSON | $644,717 | FY2013 |
| VA25612F2545 | ORTHO-CLINICAL DIAGNOSTICS, INC | 586-JACKSON | $12,483 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA586C20002_3600_VA256BP0099_3600 · retrieved 2026-09-26.